Trending GLP-1 & Weight Loss videos

Trending TikTok and Instagram videos about Ozempic, Wegovy, Mounjaro, semaglutide, and tirzepatide — each with a clinical fact-check from our medical team.

Every video on this page has been reviewed by our editorial team. We watch what creators are posting, pull out the medical claims, and check them against published clinical data. If a video gets something wrong, we say so. If it gets something right, we give credit and add context.

3,782 videos from TikTok and Instagram, sorted by view count. Use the filters below to narrow by platform or sort by date.

Browse GLP-1 & Weight Loss fact-check videos

Tirzepatide dosing charts on TikTok: what they get right and wrong

Week 7 GLP-1 progress posts: what they don't tell you

GLP-1 drugs and fatty liver: what the evidence actually shows

Mounjaro beginner tips on TikTok: what holds up?

Orforglipron phase 3 trials: what the data actually shows

Tirzepatide postpartum claims: what the science actually says

This 'natural GLP-1' supplement won't replace real medication

@juss_jenn's compound semaglutide review, fact-checked

Orforglipron hype check: what the phase 3 data actually shows

GLP-1 drugs and body transformation: sorting hype from clinical data

Losing 60 pounds in 5 months on Wegovy: fact-checking the math

Tirzepatide shot vlogs: what the science says about GLP-1 journeys

@tryalival's supplement claims for GLP-1 users, fact-checked

Can you really preserve muscle mass while losing weight on GLP-1s?

The 'biggest GLP-1 mistake' claim: what the evidence actually says

2mg semaglutide: what the dose data actually shows

Tirzepatide weight loss journeys: what TikTok skips over

GLP-1 side effects and results: what TikTok gets wrong

GLP-1 drugs and IVF: what the evidence actually supports

GLP-1 protein intake claims: what the evidence says

@daniela.segura.shop's semaglutide claims, fact-checked

GLP-1 drugs and mood or craving changes: what the evidence shows

@mbaliskhosanagp's Wegovy weight loss claims, fact-checked

Tirzepatide for obesity: separating real data from hype

Helpful Content